ASX - Delayed Quote AUD

NeuroScientific Biopharmaceuticals Limited (NSB.AX)

Compare
0.0360
-0.0030
(-7.69%)
At close: 3:31:41 PM GMT+11
Currency in AUD All numbers in thousands
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Expense
2,056.5580
2,056.5580
6,124.3600
10,503.7990
4,223.6420
Operating Income
-2,056.5580
-2,056.5580
-6,124.3600
-10,503.7990
-4,223.6420
Net Non Operating Interest Income Expense
168.9390
168.9390
102.7950
68.4500
27.5820
Other Income Expense
2,211.8290
2,211.8290
4,952.9590
--
1,018.2290
Pretax Income
324.2100
324.2100
-1,068.6060
-10,435.3490
-3,177.8310
Net Income Common Stockholders
324.2100
324.2100
-1,068.6060
-10,435.3490
-3,177.8310
Basic EPS
0.00
--
-0.01
-0.07
-0.02
Diluted EPS
0.00
--
-0.01
-0.07
-0.02
Basic Average Shares
144,508.8860
--
143,471.6430
143,471.6430
143,471.6430
Diluted Average Shares
144,508.8860
--
143,471.6430
143,471.6430
143,471.6430
Net Income from Continuing & Discontinued Operation
324.2100
324.2100
-1,068.6060
-10,435.3490
-3,177.8310
Normalized Income
324.2100
324.2100
-1,068.6060
-10,435.3490
-3,177.8310
Interest Income
178.9360
178.9360
107.5290
68.4500
27.6450
Interest Expense
9.9970
9.9970
4.7340
--
0.0630
Net Interest Income
168.9390
168.9390
102.7950
68.4500
27.5820
EBIT
334.2070
334.2070
-1,063.8720
-10,503.7990
-3,177.7680
EBITDA
425.5440
425.5440
-1,006.0180
-10,438.8840
-3,116.3610
Reconciled Depreciation
91.3370
91.3370
57.8540
64.9150
61.4070
Net Income from Continuing Operation Net Minority Interest
324.2100
324.2100
-1,068.6060
-10,435.3490
-3,177.8310
Normalized EBITDA
425.5440
425.5440
-1,006.0180
-10,438.8840
-3,116.3610
6/30/2021 - 7/27/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers